𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reboxetine for the treatment of patients with Cocaine Dependence Disorder

✍ Scribed by N. Szerman; L. Peris; B. Mesías; P. Colis; J. Rosa; A. Prieto

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
55 KB
Volume
20
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

Background Although several approaches have been attempted for cocaine dependence, the pharmacological treatment of this serious disorder remains unclear. To date, desipramine, a tricyclic antidepressant of great noradrenergic activity, has shown the best results. Reboxetine, a selective noradrenaline reuptake inhibitor, might be an effective therapeutic option for this severe drug addiction. The aim was preliminarily to assess reboxetine in a group of cocaine dependent patients, selected from The Madrid City Council Drug Addiction Program primary care centres. Method Twenty six patients with a diagnosis of cocaine dependence disorder (DSM-IV 304.20) were selected to receive open treatment with reboxetine, 8 mg/day, for 12 weeks. Follow up assessments comprised cocaine consumption, treatment retention rate and change in standard structured psychometric instrument scores: cocaine selective severity assessment, Hamilton anxiety scale, Hamilton depression scale and clinical global impression, throughout the treatment period. Results Data were obtained from 20 patients; 10 of them remained abstinent, whereas the other 10 consumed cocaine at some time during the study. The treatment retention rate at week 12 was 61.5%. The psychometric instrument mean scores showed marked decreases throughout the treatment period. Conclusion Reboxetine might be an effective and safe therapeutic option for cocaine dependence disorder. The aversive effects, as well as the high blockage reported by some patients consuming cocaine during the trial, might be related to treatment. If confirmed in large clinical trials, the trends suggested by this study would confirm the role of noradrenergic function in the treatment of cocaine dependence.

📜 SIMILAR VOLUMES

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi

Predictors of relapse in a study of dulo
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder
✍ J. Alexander Bodkin; Christer Allgulander; Pierre M. Llorca; Melissa E. Spann; D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Objective Data from a relapse prevention study of duloxetine treatment for adults with generalized anxiety disorder (GAD) were examined to identify predictors of relapse. ## Methods Patients responding to 6 months of open‐label duloxetine treatment were randomized to continuation with duloxeti

Do benzodiazepines extend the duration o
Do benzodiazepines extend the duration of follow-up treatment in patients with bipolar disorder?
✍ Gul Hwang; Hag-Ryul Kim; Sang-Hag Park; Sang-Hoon Kim; Sung-Rok Park; Gyung-Hwan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Introduction: In patients with bipolar disorder, relapse and recurrence from the premature discontinuation of pharmacotherapy are serious clinical problems. thus, clinicians must make every effort to ensure the sufficient duration of continual treatment even after the remission of acute episodes

The Australian experience of day program
The Australian experience of day programs for patients with eating disorders
✍ Thornton, Christopher ;Beumont, Peter ;Touyz, Stephen 📂 Article 📅 2002 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## Objective To describe the authors' experience in establishing and implementing day programs for the treatment of eating disorders in Australia. ## Method This is a descriptive article based on the author's experience. Five‐day programs are described in terms of their structure, th